RALLYBIO CORPORATION Effective Income Tax Rate Reconciliation, Tax Credit, Percent
RALLYBIO CORPORATION (RLYB) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -10.70% for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-08-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-08-26
- RALLYBIO CORPORATION effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -9.90%.
- RALLYBIO CORPORATION effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -6.00%, a 188.24% decline from fiscal 2021.
- RALLYBIO CORPORATION effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 6.80%, a 15.00% decline from fiscal 2020.
- RALLYBIO CORPORATION effective income tax rate reconciliation, tax credit, percent for fiscal 2020 was 8.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -10.70% S-4/A · filed 2026-08-26 | |
| 2023-12-31 | -9.90% 10-K · filed 2025-03-13 | |
| 2022-12-31 | -6.00% 10-K · filed 2024-03-12 | 6.00% 10-K · filed 2023-03-06 |
| 2021-12-31 | 6.80% 10-K · filed 2023-03-06 | |
| 2020-12-31 | 8.00% 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |